Salbutamol dry-powder inhalation - Teva Pharmaceutical Industries

Drug Profile

Salbutamol dry-powder inhalation - Teva Pharmaceutical Industries

Alternative Names: ABS eMDPI; Airmax Salamol; Albuterol DPI - Teva; Albuterol dry-powder inhalation - Teva; Albuterol eMDPI; Albuterol MDPI; Albuterol Spiromax; Albuterol sulfate - Teva; Albuterol-dry-powder-inhalation; ProAir RespiClick; Salbutamol DPI - Teva

Latest Information Update: 18 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IVAX Corporation
  • Developer Teva Pharmaceutical Industries
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma; Exercise-induced asthma
  • Phase III Chronic obstructive pulmonary disease

Most Recent Events

  • 17 Apr 2018 Teva Branded Pharmaceutical completes a phase III trial in Chronic obstructive pulmonary disease in USA (Inhalation) (NCT03256695)
  • 02 Feb 2018 Teva completes a phase III trial for Asthma in USA (Inhalation) (NCT02969408)
  • 28 Sep 2017 Phase-III clinical trials in Chronic obstructive pulmonary disease in USA (Inhalation) (NCT03256695)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top